A systematic review on the effectiveness of pharmacological interventions for chronic non-specific low-back pain

Kuijpers, T.; Middelkoop, M.; Rubinstein, S.; Ostelo, R.; Verhagen, A.; Koes, B.; Tulder, M.
January 2011
European Spine Journal;Jan2011, Vol. 20 Issue 1, p40
Academic Journal
The objective of this review was to determine the effectiveness of pharmacological interventions [i.e., non-steroid anti-inflammatory drugs (NSAIDs), muscle relaxants, antidepressants, and opioids] for non-specific chronic low-back pain (LBP). Existing Cochrane reviews for the four interventions were screened for studies fulfilling the inclusion criteria. Then, the literature searches were updated. Only randomized controlled trials on adults (≥18 years) with chronic (≥12 weeks) non-specific LBP and evaluation of at least one of the main clinically relevant outcome measures (pain, functional status, perceived recovery, or return to work) were included. The GRADE approach was used to determine the quality of evidence. A total of 17 randomized controlled trials was included: NSAIDs ( n = 4), antidepressants ( n = 5), and opioids ( n = 8). No studies were found for muscle relaxants; 14 studies had a low risk of bias. The studies only reported effects on the short term (<3 months). The overall quality of the evidence was low. NSAIDs and opioids seem to lead to a somewhat higher relief in pain on the short term, as compared to placebo, in patients with non-specific chronic low back pain; opioids seem to have a small effect in improving function for a selection of patients who responded with an exacerbation of their symptoms after stopping their medication. However, both types of medication show more adverse effects than placebo. There seems to be no difference in effect between antidepressants and placebo in patients with non-specific chronic LBP.


Related Articles

  • Are non-steroidal anti-inflammatory drugs effective for the management of neck pain and associated disorders, whiplash-associated disorders, or non-specific low back pain? A systematic review of systematic reviews by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration. Wong, Jessica; Côté, Pierre; Ameis, Arthur; Varatharajan, Sharanya; Varatharajan, Thepikaa; Shearer, Heather; Brison, Robert; Sutton, Deborah; Randhawa, Kristi; Yu, Hainan; Southerst, Danielle; Goldgrub, Rachel; Mior, Silvano; Stupar, Maja; Carroll, Linda; Taylor-Vaisey, Anne; Wong, Jessica J; Côté, Pierre; Shearer, Heather M; Brison, Robert J // European Spine Journal;Jan2016, Vol. 25 Issue 1, p34 

    Purpose: To evaluate the effectiveness of non-steroidal anti-inflammatory drugs (NSAIDs) for the management of neck pain and associated disorders (NAD), whiplash-associated disorders, and non-specific low back pain (LBP) with or without radiculopathy.Methods: We...

  • Review: non-steroidal anti-inflammatory drugs and muscle relaxants are moderately effective for low back pain. Walker, Jan // Evidence Based Nursing;Apr2008, Vol. 11 Issue 2, p50 

    The article offers information on a study which aims to determine medications that are effective for low back pain. It states that nonsteroidal anti-inflammatory drugs (NSAID) and skeletal muscle relaxants are moderately efficient for the disorder. Moreover, it says that tricyclic...

  • Nonsteroidal anti-inflammatory drugs in the treatment of low back pain. Kuritzky, Louis; Samraj, George P. // Journal of Pain Research;2012 Part 2, Vol. 5, p579 

    Low back pain (LBP) is amongst the top ten most common conditions presenting to primary care clinicians in the ambulatory setting. Further, it accounts for a significant amount of health care expenditure; indeed, over one third of all disability dollars spent in the United States is attributable...

  • Systemic Pharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline. Chou, Roger; Deyo, Richard; Friedly, Janna; Skelly, Andrea; Weimer, Melissa; Fu, Rochelle; Dana, Tracy; Kraegel, Paul; Griffin, Jessica; Grusing, Sara // Annals of Internal Medicine;4/4/2017, Vol. 166 Issue 7, p480 

    Background: A 2007 American College of Physicians guideline addressed pharmacologic options for low back pain. New evidence and medications have now become available.Purpose: To review the current evidence on systemic pharmacologic therapies for acute or chronic...

  • Risk of NSAID-induced toxicity in older adults. Sadovsky, Richard // American Family Physician;9/1/1997, Vol. 56 Issue 3, p908 

    Presents a summary of the work `Toxicity of Nonsteroidal Anti-inflammatory Drugs in the Elderly: Is Advanced Age a Risk Factor?,' by D. H. Solomon, et al. from `American Journal of Medicine' dated 1997.

  • New findings for the treatment of chronic, nonspecific low back pain. Noertjojo, Kukuh; Martin, Craig; Dunn, Celina // British Columbia Medical Journal;Jan/Feb2012, Vol. 54 Issue 1, p39 

    The article discusses findings on the treatment for low back pain (LBP), not attributable to a recognizable, specific pathology, and chronic LBP (C-LBP), which indicates the presence of LPB for more than three months. Categories of the classification systems of LBP are diagnostic, prognostic,...

  • Pharmacotherapeutic considerations for chronic pain in chronic kidney and end-stage renal disease. Mathew, Roy O.; Bettinger, Jeffrey J.; Wegrzyn, Erica L.; Fudin, Jeffrey // Journal of Pain Research;2016, Vol. 9, p1191 

    The authors look at various pharmacotherapeutic considerations for the treatment of chronic kidney and end-stage renal disease pain. Topics discussed include the basic scenarios in relation to the treatment of opioids in chronic kidney disease (CKD) patients, renal toxicities caused by...

  • Breaking a Vicious Circle? Wilke, Allan J. // Internal Medicine Alert;4/15/2010, Vol. 32 Issue 7, p49 

    In this article, the author discusses the discovery that adding a muscle relaxant to a nonsteroidal anti-inflamatory drug (NSAID) has no benefit in acute neck strain.

  • Diagnosis and Treatment of Temporomandibular Disorders. GAUER, ROBERT L.; SEMIDEY, MICHAEL J. // American Family Physician;3/15/2015, Vol. 91 Issue 6, p378 

    Temporomandibular disorders (TMD) are a heterogeneous group of musculoskeletal and neuromuscular conditions involving the temporomandibular joint complex, and surrounding musculature and osseous components. TMD affects up to 15% of adults, with a peak incidence at 20 to 40 years of age. TMD is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics